Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 536
Name: Organic compounds -- part of the class 532-570 series >
Description:










Class Number Class Name No. of Patents
 

Organic compounds (class 532, subclass 1)

 
536/1.11

Carbohydrates or derivatives

730
536/3

Algin or derivative

143
536/56

Cellulose or derivative

538
536/58

Esters

158
536/63

Carboxylic acid esters

156
536/69

Acetates

157
536/83

Halogen containing compound utilized in process

13
536/76

Subsequent treatment process

98
536/77

Comminuting or centrifuging

12
536/79

Corrosiveness reduced

6
536/82

Halogen containing compound utilized in process

21
536/78

Recovery from photographic film

7
536/81

Stabilizing

12
536/80

Viscosity or degree of polymerization changed (e.g., degrading, cross linking, etc.)

36
536/70

With pretreatment process

32
536/71

Acetic acid utilized in pretreatment

29
536/72

Halogen containing compound utilized in process

8
536/73

Sulfur containing compound utilized in pretreatment

10
536/75

Halogen containing compound utilized in process

6
536/74

Sulfur containing compound utilized in pretreatment

8
536/66

Ether-esters

47
536/67

Formates

19
536/64

Mixed carboxylate esters

74
536/65

Propionate, butyrate or isobutyrate containing

68
536/68

Propionates, butyrates or isobutyrates

56
536/62

Phosphorus containing acid

34
536/59

Sulfur containing acid

72
536/60

Xanthate or viscose

37
536/61

Subsequent treatment process

35
536/84

Ethers

240
536/99

Alkyl or cycloalkyl

72
536/100

Ethyl

43
536/97

Carboxyalkyl or salts thereof

52
536/98

Carboxymethyl or salts thereof

121
536/95

Hydroxyalkyl containing

106
536/96

Hydroxyethyl

95
536/90

Mixed ethers

109
536/91

Hydroxyalkyl containing

138
536/85

Subsequent treatment process

99
536/89

Acid employed in subsequent treatment

29
536/86

Comminuting

27
536/87

Liquid interaction properties changed (e.g., solubility, absorbability, etc.)

65
536/88

Viscosity, degree of polymerization or heat stability changed (e.g., degrading, cross-linking, etc.)

87
536/92

Sulfur containing

42
536/93

Unsaturated

26
536/94

Aromatic nucleus containing

14
536/101

Metal containing

65
536/57

Regenerated cellulose

131
536/112

Dextran or derivative

246
536/113

Iron containing

31
536/115

Esters

336
536/119

Carboxylic

449
536/116

Ether-esters

111
536/117

Phosphorus containing

183
536/118

Sulfur containing

207
536/120

Ethers

469
536/114

Gums or derivatives

417
536/121

Metal containing

186
536/18.7

Nitrogen containing

804
536/29.2

C-glycosides wherein the sugar ring is bonded directly to carbon of an n-hetero ring (e.g., 9-deazaadenosines, etc.)

76
536/30

Cellulose derivatives

159
536/32

Esters

75
536/35

Nitrates

25
536/36

Mixed esters

18
536/38

Subsequent treatment process

29
536/39

Comminuting

2
536/40

Recovery from photographic film

3
536/42

Stabilizing

4
536/41

Viscosity or degree of polymerization changed (e.g., degrading, cross linking, etc.)

22
536/37

With pretreatment process

9
536/34

Phosphorus containing acid

13
536/33

Sulfur containing acid

21
536/43

Ethers

94
536/44

Mixed ethers

44
536/31

Nitrogen containing hetero ring (e.g., morpholine, etc.)

46
536/20

Chitin or derivative

398
536/51

Dextran derivatives

113
536/55.2

Glucosamine containing

378
536/52

Gum derivatives

65
536/21

Heparin or derivative

378
536/22.1

N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.)

2175
536/25.2

2`-5` linked rna

64
536/25.1

3`-5` linked rna

129
536/23.1

Dna or rna fragments or modified forms thereof (e.g., genes, etc.)

18347
536/23.4

Encodes a fusion protein

2809
536/23.7

Encodes a microbial polypeptide

3208
536/23.71

Bacillus thuringiensis insect toxin

375
536/23.74

Fungal protein

336
536/23.72

Viral protein

1735
536/23.6

Encodes a plant polypeptide

2613
536/23.5

Encodes an animal polypeptide

7816
536/23.51

Hormone

637
536/23.53

Immunoglobulin

777
536/23.52

Interferon

197
536/23.2

Encodes an enzyme

8449
536/24.2

Non-coding sequences having no known regulatory function which are adaptors or linkers for vector or gene contruction

530
536/24.1

Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.)

4824
536/24.5

Nucleic acid expression inhibitors

3671
536/24.3

Probes for detection of specific nucleotide sequences or primers for the synthesis of dna or rna

6244
536/24.33

Primers

3967
536/24.31

Probes for detection of animal nucleotide sequences

3304
536/24.32

Probes for detection of microbial nucleotide sequences

2025
536/25.5

Homopolymers having repeating sequences of four or more identical nucleotide units

78
536/28.6

N-glycosides wherein the n is part of a five-membered hetero ring (e.g., selenazole nucleosides, pyrrole nucleosides, etc.)

68
536/28.7

Plural nitrogens in the n-hetero ring (e.g., triazoles, etc.)

56
536/28.8

The n-hetero ring is a 1,3-diazole ring, including hydrogenated (e.g., imidazoles, etc.)

52
536/28.9

Benzimidazoles

32
536/28.1

N-glycosides wherein the n is part of a six-membered hetero ring (e.g., diazines, etc.)

244
536/28.2

Multideoxy or didehydro

174
536/28.4

The n-hetero ring is a 1,3-diazine ring, including hydrogenated (e.g., pyrimidines, etc.)

146
536/28.53

Chalcogen bonded directly to the 2- and 4-positions of the diazine ring (e.g., uridine, etc.)

290
536/28.54

Alkyl, or substituted alkyl, bonded directly to the 5-position of the diazine ring (e.g., thymidine, 5-methyl uridine, etc.)

256
536/28.55

Halogen bonded directly to the 5-position of the diazine ring (e.g., 5-fluorouridine, etc.)

155
536/28.5

Nitrogen, other than nitro or nitroso, bonded directly to the 4-position, and chalcogen bonded directly to the 2-position of the diazine ring (e.g., cytidines, etc.)

318
536/28.52

Halogen or alkyl group of 1-5 carbon atoms bonded directly to the 5-position of the diazine ring

148
536/28.51

Having chalcogen, carbonyl, or thiocarbonyl bonded directly to the 4-position substituent nitrogen

122
536/28.3

The n-hetero ring is a triazine ring, including hydrogenated (e.g., 6-azauridine, etc.)

56
536/27.1

N-glycosides wherein the n is part of an n-hetero ring which hetero ring is part of a polycyclo ring system containing an n-hetero ring and an additional hetero ring (e.g., rebeccamycin, etc.)

235
536/27.13

Bicyclic ring system consisting of the n-hetero ring fused to another hetero ring (e.g., 2-azaadenines, 6-azaadenines, etc.)

164
536/27.14

Multideoxy or didehydro

156
536/27.2

The bicyclic ring system consists of a 1,3-diazine ring, which may be hydrogenated, fused to a five-membered n-hetero ring (e.g., purine isoesters like tubercidin, toyocamycin, sangivamycin, sparsomycin a, etc.)

125
536/27.21

The five-membered n-hetero ring is 1,3-diazole, which may be hydrogenated (e.g., 6-chloropurine nucleoside, nebularin, etc.)

135
536/27.4

Arabinose is sugar moiety

72
536/27.23

Carbonyl, thiocarbonyl, additional hetero ring or nitrogen, other than as nitro or nitroso, attached indirectly to the sugar ring by acyclic nonionic bonding

88
536/27.3

Adenosyl

132
536/27.31

S-adenosyl-l-methionine, s-adenosyl-l-homocysteine, salts, or esters thereof

36
536/27.22

Carbonyl, thiocarbonyl, or nitrogen, other than as nitro or nitroso, bonded directly to the sugar ring

61
536/27.8

Chalcogen bonded directly to the 6- or 2-position of a purine ring system (e.g., inosine, etc.)

150
536/27.81

Nitrogen, other than nitro or nitroso, bonded directly to the 2-position of the purine ring system (e.g., guanosine, etc.)

216
536/27.5

Ketose is sugar moiety (e.g., decoyinine, psicofuranosylpurines, etc.)

7
536/27.6

Nitrogen, other than nitro or nitroso, bonded directly to the 6-position of a purine ring system (e.g., adenosine, etc.)

293
536/27.61

Additional nitrogen bonded directly to the 2-position of the purine ring system

117
536/27.7

Chalcogen, halogen, or benzene bonded directly to carbon of the purine ring system (e.g., isoguanosine, 2-fluoroadenosine, etc.)

104
536/27.62

Nitrogen, chalcogen, or additional carbon bonded directly to the 6-position nitrogen (e.g., 6-position nitrogen is substituted, etc.)

182
536/27.63

Halogen, chalcogen, or cyano bonded directly to the 2-position of the purine ring system

149
536/27.11

Preparing by cleaving nucleic acids or by attaching an n-heterocyclic base to a sugar ring

137
536/27.12

Separation or purification (e.g., resolving isomeric mixtures, etc.)

39
536/29.1

Nitrogen of n-glycoside is acyclic nitrogen

117
536/29.11

N-hetero ring bonded directly or indirectly to the acyclic nitrogen

33
536/29.13

Sulfur containing (e.g., sulfides, sulfones, sulfates, sulfonamides, etc.)

15
536/29.12

The acyclic nitrogen is part of a urea or thiourea group

47
536/25.6

Nucleic acids which include two or three nucleotide units

167
536/26.1

Phosphorus containing n-glycoside wherein the n is part of an n-hetero ring

229
536/26.44

Cobalamin analogs (i.e., compounds wherein the benzimidazole ring system has been replaced by another organic ring structure, or compounds wherein cobalt has been removed or replaced by another metal, or is substituted by a group other than -oh or -cn)

28
536/26.4

Cobalamin nucleotides (e.g., vitamin b-12, etc.)

47
536/26.42

Processes of concentraction, separation, recovery, or extraction (e.g., recovery from organ extracts, from fermentation broth, from sewage sludge, etc.)

14
536/26.43

Adsorbent used (e.g., activated alumina, ion exchange resins, etc.)

6
536/26.41

Processes of preparing or labelling

27
536/26.6

Labelled (e.g., tagged with radioactive tracer, fluorescent marker, intercalator, etc.)

599
536/26.5

Plural n-glycosidic moieties bonded to the same phosphorus ester group

52
536/26.2

Plural phosphorus atoms in n-glycoside

60
536/26.3

Plural monophosphate groups (e.g., adenosine-3`, 5`-biscarboxymethyl phosphonate, cytidine nucleoside diphosphate, etc.)

40
536/26.21

Plural phosphorus atoms bonded directly to the same chalcogen in a chain (e.g., pyrophosphates, polyanhydrides of phosphorus acids, etc.)

65
536/26.22

Both terminal phosphorus atoms are esterified by organic groups wherein one of these organic groups is the sugar moiety

44
536/26.23

Exactly two phosphorus atoms in the chain (e.g., coenzyme a, etc.)

134
536/26.25

Fad (flavin adenine dinucleotide) and derivatives thereof

14
536/26.24

Nad (nicotinamide adenine dinucleotide) and derivatives thereof

54
536/26.26

Triphosphates (in same chain)

193
536/26.9

The n-hereto ring is five-membered (e.g., 1- -d-riboburanosyl-1, 2,3- triazole-4-carboxamide-5`-phosphate, etc.)

46
536/26.8

The n-hereto ring is six-membered and monocyclic (e.g., uridine-5`-mono- phosphate, etc.)

308
536/26.7

The n-hetero ring is part of a bicyclic ring system

289
536/26.74

Inosine nucleotide

51
536/26.71

Preparing purine nucleotides

109
536/26.72

Guanosine nucleotide preparation

52
536/26.73

Separation or purification of purine nucleotides

26
536/26.11

The phosphorus is part of a ring

24
536/26.14

The n-hetero ring is a diazine or a diazole ring, including hydrogenated

20
536/26.12

The n-hetero ring is part of a purine ring system

48
536/26.13

Adenine or substituted adenine

78
536/25.4

Separation or purification of polynucleotides or oligonucleotides

786
536/25.41

Extraction processes (e.g., solvent extraction process, etc.)

235
536/25.42

Denaturant utilized

129
536/25.3

Synthesis of polynucleotides or oligonucleotides

1840
536/25.31

Deprotection step

342
536/25.32

Labels or markers utilized (e.g., radiotracer, affinity, fluoroescent, phosphorescent, markers, etc.)

773
536/25.33

Pentavalent phosphorus compound utilized

273
536/25.34

Trivalent phosphorus compound utilized

402
536/53

Oxygen double bonded and nitrogen bonded directly to the same carbon

582
536/55

Plural nitrogens containing

226
536/55.1

Polysaccharides

506
536/55.3

Processes

477
536/45

Starch derivatives

136
536/47

Cross-linked

36
536/46

Dextrin derivatives

146
536/48

Esters

51
536/49

Ether-esters or mixed esters

29
536/50

Ethers

84
536/54

Sulfur containing

187
536/4.1

O- or s- glycosides

1516
536/4.4

Aescin or derivative

16
536/13.1

Antibiotic bm 123 or derivative

13
536/13.4

Antibiotic xk or derivative

23
536/16.8

Antibiotics

387
536/16.9

Purification or recovery

40
536/17.1

Boron, phosphorus, heavy metal or aluminum containing

171
536/13.5

Butirosin or derivative (e.g., ambutyrosin, etc.)

29
536/18.2

Containing -c(=x)x- wherein the x's are the same or diverse chalcogens

197
536/8.8

Coumermycin or derivative

5
536/5

Cyclopentanohydrophenanthrene ring system

234
536/6.1

Oxygen containing five-membered hetero ring

57
536/6.2

Nitrogen, phosphorus or halogen containing

36
536/6.3

Processes of extracting from plant materials

20
536/6

Oxygen containing six-membered hetero ring (e.g., oxathiane, etc.)

65
536/6.4

Daunomycin or derivative

379
536/8

Flavon sugar compounds

141
536/16.1

Fortimicin or derivative

91
536/13.6

Gentamicin or derivative

104
536/18.4

Halogen containing

155
536/13.7

Kanamycin or derivative

89
536/13.8

Carbonyl bonded directly to kanamycin nitrogen

71
536/16.7

Kasugamycin or derivative

8
536/16.2

Lincomycin or derivative

27
536/16.4

Additional sulfur containing

8
536/16.3

Cyano or -coo- containing

12
536/16.5

Phosphorus or halogen containing

20
536/16.6

Neamine or derivative (e.g., neomycin a, etc.)

50
536/13.2

Neomycin b or neomycin c or derivative

37
536/17.2

Nitrogen containing

603
536/17.7

Nitro or nitroso containing

52
536/17.8

Nitrogen in aglycone moiety

27
536/17.3

Nitrogen containing hetero ring

180
536/17.4

Nitrogen in aglycone moiety

328
536/17.9

Nitrogen in aglycone moiety

418
536/17.5

Sulfur containing (e.g., methylthiolincosaminide, etc.)

170
536/17.6

Nitrogen or sulfur in aglycone moiety

122
536/13

Novobiocin or derivative

18
536/7.1

Oxygen containing hetero ring having 12-19 members (e.g., methymycin, carbomycin, spiramycin, etc.)

391
536/7.2

Erythromycin or derivative (e.g., oleandomycin, etc.)

338
536/7.4

Additional nitrogen containing

389
536/7.3

Boron, phosphorus or sulfur containing

93
536/7.5

Purification or recovery

25
536/6.5

Oxygen containing hetero ring having at least twenty members (e.g., amphotericin, nystatin, pimaricin, etc.)

114
536/13.3

Paromomycin or derivative (e.g., neomycin e, etc.)

35
536/18.3

Plural oxyalkylene groups bonded directly to each other

73
536/18.1

Polycyclo ring system (e.g., hellebrin, etc.)

486
536/18.5

Processes

724
536/18.6

Reacting a carbohydrate with an organic -o- containing compound (e.g., reacting glucose with methanol, etc.)

433
536/13.9

Sisomicin or derivative

65
536/14

Streptomycin or derivative

24
536/16

Addition compounds

7
536/15

Dihydrostreptomycin or derivative

7
536/2

Pectin or derivative

131
536/123

Plural diverse saccharides containing (e.g., hetero polysaccharides, etc.)

543
536/123.1

Polysaccharides

1184
536/123.13

Disaccharides (e.g., maltose, sucrose, lactose, formaldehyde lactose, etc.)

390
536/123.12

Glucans (e.g., pullulan, etc.)

277
536/124

Processes

1827
536/125

Isomerization

81
536/126

Polymerization

152
536/127

Purification or recovery

646
536/128

From plant material

318
536/102

Starch or derivative

388
536/104

Aldehyde reaction product

51
536/106

Cross-linked

112
536/103

Dextrin or derivative

548
536/107

Esters

101
536/110

Carboxylic

95
536/108

Ether-esters or mixed esters

46
536/109

Phosphorus or sulfur containing

34
536/111

Ethers

143
536/105

Oxidized starch or derivative

104
536/122

Sulfur or halogen containing

350
 
 
  Recently Added Patents
Positioning vehicles to improve quality of observations at intersections
Method and apparatus for increasing query traffic to a web site
Integrated circuit having a discrete capacitor mounted on a semiconductor die
Tomlinson Harashima precoding with additional receiver processing in a multi-user multiple-input multiple-output wireless transmission system
Method for detecting directions of regularity in a two-dimensional image
Phosphor adhesive sheet, light emitting diode element including phosphor layer, light emitting diode device, and producing methods thereof
Electrophoresis display having touch screen and method for driving the touch screen
  Randomly Featured Patents
Sound surge detector for alerting headphone users
Rear bumper for automobile
Measurement of gas and water content in oil
Solid state image sensor unit with wide dynamic range and high resolution
Ski trail resurfacing apparatus
Electromagnetic counters
Method and device for determining the motion vector tissues in a biological medium
Liquid crystal display device
Violin bridge for a stringed instrument
Electronic game board assembly